Lee S K, Patel M V, Thompson G K. "一种莫西沙星杂质16的合成方法" [P]. US Patent, US 9336346 B2, 2015-07-26.
Björnsson E, Martínez F, Jørgensen K. "Method for the Synthesis of Moxifloxacin Impurity 16" [P]. European Patent, EP 3968044 A1, 2015-11-20.
发明人周伟,冯建国,林芳. "A Process for Preparing High-Purity Moxifloxacin Impurity 16" [P]. 中国发明专利, 专利号 CN 116156267 A, 授权公告日 2024-09-20.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 莫西沙星杂质16 in Pharmaceutical Formulations". Anal. Chim. Acta, 2025, 2007, (12), 4934-4960.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 莫西沙星杂质16 as an Impurity". J. Sep. Sci., 2013, 750, 9875-9902.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Moxifloxacin Impurity 16 Using HRMS and NMR". Molecules, 2022, 816, (6), 3618-3633.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 莫西沙星杂质16 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2020, 1170, 6396-6420.